Protein– tag –
-
FDA Approves Dawnzera: RNA-Targeting ASO Marks Paradigm Shift for Hereditary Angioedema
Liv Hospital Turkey Overview In August 2025, the FDA granted approval to Dawnzera (donidalorsen-azyh), a groundbreaking RNA-targeting antisense oligonucleotide (ASO) for hereditary angioedema (HAE). By specifically silencing prekallikrei... -
6th mRNA Therapeutics Summit Highlights Shift to Oncology, with In Vivo CAR-T, saRNA, and circRNA as Key Innovations
BioSpace USA Overview The 6th mRNA-Based Therapeutics Summit revealed a significant shift in mRNA clinical activity from infectious diseases to oncology, with in vivo CAR-T emerging as a notable application. Self-amplifying RNA (saRNA) a... -
New England Biolabs Unveils Comprehensive RNA Workflow Reagents Supporting mRNA Therapeutics and Diagnostics
New England Biolabs USA Overview New England Biolabs has announced an expanded portfolio of reagents to support various RNA research workflows, including mRNA therapeutics, personalized medicine, and diagnostics. The company highlights t... -
Schrödinger Unveils ‘Bunsen’ AI Co-Scientist to Accelerate End-to-End Biologics Discovery Workflow with BioLuminate and LiveDesign Integration
Schrödinger USA Overview Schrödinger is hosting an event to demonstrate an integrated, end-to-end workflow accelerating biologics discovery and engineering through BioLuminate and LiveDesign. A highlight of this session is the introducti... -
Generate Biomedicines’ AI-Designed Antibody GB-0895 Advances to Global Phase 3 for Severe Asthma; Insilico Medicine’s IPF Drug also Reaches Phase 3
Stock Titan USA Overview Generate Biomedicines announced its AI-designed anti-TSLP monoclonal antibody, GB-0895, has advanced to global Phase 3 clinical trials for severe asthma, highlighted in its Q2 2026 financial results. Novartis has... -
Isomorphic Labs: AI-Designed Drugs Head to Human Trials, Reshaping Pharma’s Future
Wired USA Overview Isomorphic Labs, a Google DeepMind spin-off, is on the verge of commencing human clinical trials for drugs entirely designed by artificial intelligence. Leveraging its foundational AlphaFold system, the company aims to... -
Chemically Defined, Serum-Free Media Innovations Drive Market Expansion: AuctuCel Launches AI-Powered Medium, Gibco Achieves High CHO Cell Titer
Media City Scientific Singapore Overview Innovations in serum-free and chemically defined media are rapidly advancing, eliminating animal-derived components and boosting reproducibility in cell culture. Qkine launched FRS™ Pioneer, while... -
Bioreactor-Based Transient Transfection with HEK 293-F Cells Unlocks Large-Scale HPV VLP Production
MDPI Switzerland Overview A recent study demonstrates a significant advance in biopharmaceutical manufacturing, achieving highly efficient, large-scale production of HPV16 L1/L2 chimeric virus-like particles (VLPs). By leveraging transie... -
AGC Biologics: Job Posting Reveals Broad Biomanufacturing Scope, Spanning Proteins to Gene Therapies
Myworkdayjobs.com USA Overview A recent student assistant job posting from AGC Biologics has inadvertently showcased the company's remarkably extensive Contract Development and Manufacturing Organization (CDMO) capabilities. The company ... -
Cell Membrane-Coated Nanoparticles: New Strategy for Diabetic Wound Healing, Macrophage and Mesenchymal Stem Cell Membranes Show Significant Anti-Inflammatory, Angiogenic, and Tissue Repair Effects
PMC (PubMed Central) International Overview Nanoparticles are a promising platform for drug delivery, and specifically for diabetic wound healing, cell membrane-coated nanoparticles have emerged as an innovative strategy due to their inh...
